Related Experiment Video

Updated: Sep 28, 2026

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

[Juvenile myoclonic epilepsy in chromosome 6p12: clinical and genetic advances]

A V Delgado-Escueta1, D Bai, J Bailey

  • 1Epilepsy Genetics/Genomics Laboratories, West Los Angeles VA GLAHS Medical Center, Los Angeles, CA 90073, USA. escueta@ucla.edu

Revista De Neurologia
|October 22, 2002
PubMed

Insights

Juvenile myoclonic epilepsy (JME) is a common epilepsy syndrome. Researchers have identified the myoclonin gene on chromosome 6p12, offering new insights into JME

Area of Science:

  • Genetics
  • Neurology
  • Epilepsy Research

Context:

  • Juvenile myoclonic epilepsy (JME) is the most prevalent form of idiopathic generalized epilepsy.
  • Classic JME presents with specific seizure types and EEG patterns in adolescence.
  • While typically lacking absences, some JME patients exhibit rare polyspike wave absences.

Purpose:

  • To identify the specific gene responsible for classic JME.
  • To refine the genetic locus (EJM1) for JME.
  • To investigate the function of the identified gene in JME pathogenesis.

Summary:

  • Genetic linkage studies mapped classic JME to chromosome 6p12 (EJM1).
  • Further refinement narrowed the EJM1 locus using advanced mapping techniques and genetic markers.
  • The putative JME gene, myoclonin, was identified in the 6p12 region.

Impact:

  • Discovery of the myoclonin gene provides a molecular basis for JME.
  • Understanding the gene's function can elucidate JME pathophysiology.
  • This finding has significant implications for the broader JME patient population.

More Related Videos

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

Ex Vivo Calcium Imaging for Drosophila Model of Epilepsy04:41

Ex Vivo Calcium Imaging for Drosophila Model of Epilepsy

Published on: October 13, 2023

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...